A method for treating an immunology-related disease. The method involves administering to a mammal in need thereof a pharmaceutically effective amount of an amino acid compound, a pharmacologically acceptable salt thereof or a pharmacologically acceptable ester thereof. The compound has the following formula:
, wherein R
1
and R
2
are each hydrogen; R
3
is hydrogen; R
4
is C
1
-C
2
alkyl; n is 2; X is ═N-D, wherein D is hydrogen, C
1
-C
4
alkyl or phenyl; Y is ethylene, ethynylene, —CO—CH
2
or phenylene; Z is ethylene or trimethylene; R
5
is unsubstituted C
3
-C
10
cycloalkyl, unsubstituted C
3
-C
10
aryl, or C
3
-C
10
cycloalkyl or C
6
-C
10
aryl substituted with 1 to 3 substituents selected from the group consisting of halogen, lower alkyl, halogeno lower alkyl and lower alkoxy; and R
6
and R
7
are each hydrogen.
一种治疗免疫相关疾病的方法。该方法涉及向需要治疗的哺乳动物中注射药物有效量的
氨基酸化合物,其药理学上可接受的盐或其药理学上可接受的酯。该化合物具有以下式子:其中R1和R2均为氢;R3为氢;R4为C1-C2烷基;n为2;X为═N-D,其中D为氢、C1-C4烷基或苯基;Y为
乙烯、
乙炔基、—CO—
CH2或苯基;Z为
乙烯或三亚甲基;R5为未取代的C3-C10环烷基、未取代的C3-C10芳基或取代有1至3个卤素、低烷基、卤代低烷基和低烷氧基的C3-C10环烷基或C6-C10芳基;R6和R7均为氢。